HILPDA and glioblastoma: A myriad of studies have revealed key receptors and factors for angiogenesis in GBM, which serve as diagnostic markers and therapeutic targets, such as vascular epithelial growth factor (VEGF), hypoxia‐inducible gene 2 (HIG2), and angiopoietins (Angs).7